您的位置: 首页 > 农业专利 > 详情页

Oncological and Neurological Therapy based on ATM, CHK2 and p53 proteins for DNA correction of transcription errors
专利权人:
Pedro Brito da Silva Correia
发明人:
Pedro Brito da Silva Correia
申请号:
US15626132
公开号:
US20180360923A1
申请日:
2017.06.18
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Important diseases are caused by mutations in some genes of DNA, like cancer and several neurologic diseases. These mutations are corrected in healthy humans by a complex mechanism triggered by the proteins ATM, CHK2 and p53. These proteins cause apoptosis, whenever the transcription error in DNA is too large to be corrected.This mechanism does not work if the genes encoding several proteins, mainly ATM, CHK2 and p53, are naturally mutated or are experimentally removed in rats using CRISPR or similar processes.We claim the therapeutic use of the proteins ATM, CHK2 and p53 to activate the natural mechanism of DNA transcription correction.These proteins are identical to those existing in healthy cells, and are already being produced for research or diagnosis purposes by monoclonal processes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充